Rosen, leading investor counsel, encourages lifecore biomedical, inc. investors to secure counsel before important deadline in securities class action – lfcr

New york, aug. 26, 2024 (globe newswire) -- why: rosen law firm, a global investor rights law firm, reminds purchasers of securities of lifecore biomedical, inc. (nasdaq: lfcr) between october 7, 2020 and march 19, 2024, both dates inclusive (the “class period”), of the important september 27, 2024 lead plaintiff deadline.
LFCR Ratings Summary
LFCR Quant Ranking